Kim, Sangmin <br/><br/>
Pifithrin-α, an inhibitor of p53 transactivation, up-regulates COX-2 expression through an MAPK-dependent pathway.  [electronic resource] 

 -  Pharmacology  2010 
 - 313-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1423-0313 
<br/><br/><label>Standard No.: </label>10.1159/000321327  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Benzothiazoles--administration & dosage<br/>Breast Neoplasms--pathology<br/>Cell Line, Tumor<br/>Cells, Cultured<br/>Cyclooxygenase 2--genetics<br/>Dose-Response Relationship, Drug<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>Female<br/>Fibroblasts<br/>Humans<br/>MAP Kinase Kinase Kinases--metabolism<br/>Mitogen-Activated Protein Kinases--metabolism<br/>Phosphorylation--drug effects<br/>Toluene--administration & dosage<br/>Tumor Suppressor Protein p53--metabolism<br/>Up-Regulation--drug effects